Evidence mapPaperPMID 42543454Full record

ArticleMedical & biological engineering & computing2026

Prediction and critical feature analysis for coronary artery calcification progression.

Ran Liu, Gaojian Yang, Wenyu Huang, Junyan Zhang, Yuting Lei, Rui Zhang, Zhongxiu Chen, Yong He, Hongmei Yan, Kaiyue Diao

Abstract read
PubMed Publisher
In one paragraph

Article in Medical & biological engineering & computing, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ran Liu *The Clinical Hospital of Chengdu Brain Science Institute, MOE Key Lab for Neuroinformation, School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, Sichuan, 610054, China.
Gaojian Yang *The Clinical Hospital of Chengdu Brain Science Institute, MOE Key Lab for Neuroinformation, School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, Sichuan, 610054, China.
Wenyu HuangDepartment of Radiology, West China Hospital of Sichuan University, Chengdu, Sichuan, 610041, China.
Junyan ZhangDepartment of Cardiology, West China Hospital of Sichuan University, Chengdu, Sichuan, 610041, China.
Yuting LeiIntegrated Care Management Center, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China.
Rui ZhangEngineering Research Center of Medical Information Technology, Ministry of Education, West China Hospital of Sichuan University, Chengdu, Sichuan, 610041, China.
Zhongxiu ChenDepartment of Cardiology, West China Hospital of Sichuan University, Chengdu, Sichuan, 610041, China.
Yong HeDepartment of Cardiology, West China Hospital of Sichuan University, Chengdu, Sichuan, 610041, China.
Hongmei YanThe Clinical Hospital of Chengdu Brain Science Institute, MOE Key Lab for Neuroinformation, School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, Sichuan, 610054, China. hmyan@uestc.edu.cn.
Kaiyue DiaoDepartment of Radiology, West China Hospital of Sichuan University, Chengdu, Sichuan, 610041, China. kaiyuediao@wchscu.cn.

Funding

National Natural Science Foundation of China (62276051), S&T Special Program of Huzhou(2024GZ05) 62276051National Natural Science Foundation of China (grant number: 82200553) 82200553the Project of Science and Technology Department of Sichuan Province (2026NSFSC1714) 2026NSFSC1714
6 · The paper itself

Abstract

Coronary calcification is a prevalent pathology and strong cardiovascular indicator. However, its progression drivers remain poorly defined. With limited clinical samples, it is unclear if simple traditional machine learning can effectively predict progression, challenging risk assessment and individualized treatment. We assembled a serial CCTA dataset of 2,579 patients from West China Hospital. Using Random Forest, Gradient Boosting Decision Trees, XGBoost, and Logistic Regression with SHAP analysis, we identified key features of coronary artery calcification progression and built predictive models, then compared them with traditional clinical models. The Random Forest (RF) model achieved an AUC of 0.81 (95% CI: 0.78-0.84) vs. 0.64 (0.59-0.68) for the traditional model. Baseline CACS, plaque burden, and other CCTA features were key predictors, with critical thresholds determined. A coronary artery calcification progression prediction score (CACPPS) was derived to quantify personalized progression risk. The RF model also showed acceptable calibration (Brier score = 0.169; Hosmer-Lemeshow p = 0.415), favorable decision-curve net benefit, and an optimal CACPPS threshold of 0.566. In patients with suspected or confirmed CAD, a traditional yet interpretable machine learning model can predict CACS progression and generate CACPPS to support treatment decisions and dynamic individualized management, mitigating black-box concerns through indirect interpretability.

Indexed as

CCTACoronary artery calcificationMachine learningSHAP

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.